#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The C-Terminal Domain of the Arabinosyltransferase EmbC Is a Lectin-Like Carbohydrate Binding Module


The d-arabinan-containing polymers arabinogalactan (AG) and lipoarabinomannan (LAM) are essential components of the unique cell envelope of the pathogen Mycobacterium tuberculosis. Biosynthesis of AG and LAM involves a series of membrane-embedded arabinofuranosyl (Araf) transferases whose structures are largely uncharacterised, despite the fact that several of them are pharmacological targets of ethambutol, a frontline drug in tuberculosis therapy. Herein, we present the crystal structure of the C-terminal hydrophilic domain of the ethambutol-sensitive Araf transferase M. tuberculosis EmbC, which is essential for LAM synthesis. The structure of the C-terminal domain of EmbC (EmbCCT) encompasses two sub-domains of different folds, of which subdomain II shows distinct similarity to lectin-like carbohydrate-binding modules (CBM). Co-crystallisation with a cell wall-derived di-arabinoside acceptor analogue and structural comparison with ligand-bound CBMs suggest that EmbCCT contains two separate carbohydrate binding sites, associated with subdomains I and II, respectively. Single-residue substitution of conserved tryptophan residues (Trp868, Trp985) at these respective sites inhibited EmbC-catalysed extension of LAM. The same substitutions differentially abrogated binding of di- and penta-arabinofuranoside acceptor analogues to EmbCCT, linking the loss of activity to compromised acceptor substrate binding, indicating the presence of two separate carbohydrate binding sites, and demonstrating that subdomain II indeed functions as a carbohydrate-binding module. This work provides the first step towards unravelling the structure and function of a GT-C-type glycosyltransferase that is essential in M. tuberculosis.


Vyšlo v časopise: The C-Terminal Domain of the Arabinosyltransferase EmbC Is a Lectin-Like Carbohydrate Binding Module. PLoS Pathog 7(2): e32767. doi:10.1371/journal.ppat.1001299
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001299

Souhrn

The d-arabinan-containing polymers arabinogalactan (AG) and lipoarabinomannan (LAM) are essential components of the unique cell envelope of the pathogen Mycobacterium tuberculosis. Biosynthesis of AG and LAM involves a series of membrane-embedded arabinofuranosyl (Araf) transferases whose structures are largely uncharacterised, despite the fact that several of them are pharmacological targets of ethambutol, a frontline drug in tuberculosis therapy. Herein, we present the crystal structure of the C-terminal hydrophilic domain of the ethambutol-sensitive Araf transferase M. tuberculosis EmbC, which is essential for LAM synthesis. The structure of the C-terminal domain of EmbC (EmbCCT) encompasses two sub-domains of different folds, of which subdomain II shows distinct similarity to lectin-like carbohydrate-binding modules (CBM). Co-crystallisation with a cell wall-derived di-arabinoside acceptor analogue and structural comparison with ligand-bound CBMs suggest that EmbCCT contains two separate carbohydrate binding sites, associated with subdomains I and II, respectively. Single-residue substitution of conserved tryptophan residues (Trp868, Trp985) at these respective sites inhibited EmbC-catalysed extension of LAM. The same substitutions differentially abrogated binding of di- and penta-arabinofuranoside acceptor analogues to EmbCCT, linking the loss of activity to compromised acceptor substrate binding, indicating the presence of two separate carbohydrate binding sites, and demonstrating that subdomain II indeed functions as a carbohydrate-binding module. This work provides the first step towards unravelling the structure and function of a GT-C-type glycosyltransferase that is essential in M. tuberculosis.


Zdroje

1. World Health Organisation 2009 Global Tuberculosis Control: a short update to the 2009 report (http://www.who.int/entity/tb/publications/2009/factsheet_tb_2009update_dec09.pdf)

2. HarriesAD

DyeC

2006 Tuberculosis. Ann Trop Med Parasitol 100 415 431

3. JainA

MondalR

2008 Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol 53 145 150

4. CrickDC

MahapatraS

BrennanPJ

2001 Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis. Glycobiology 11 107R 118R

5. BrikenV

PorcelliSA

BesraGS

KremerL

2004 Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 53 391 403

6. BelangerAE

BesraGS

FordME

MikusovaK

BelisleJT

1996 The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci U S A 93 11919 11924

7. TelentiA

PhilippWJ

SreevatsanS

BernasconiC

StockbauerKE

1997 The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3 567 570

8. EscuyerVE

LetyMA

TorrellesJB

KhooKH

TangJB

2001 The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J Biol Chem 276 48854 48862

9. ZhangN

TorrellesJB

McNeilMR

EscuyerVE

KhooKH

2003 The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol Microbiol 50 69 76

10. BergS

StarbuckJ

TorrellesJB

VissaVD

CrickDC

2005 Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan. J Biol Chem 280 5651 5663

11. ShiL

BergS

LeeA

SpencerJS

ZhangJ

2006 The carboxy terminus of EmbC from Mycobacterium smegmatis mediates chain length extension of the Arabinan in lipoarabinomannan. J Biol Chem 281 19512 19526

12. AlderwickLJ

SeidelM

SahmH

BesraGS

EggelingL

2006 Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J Biol Chem 281 15653 15661

13. SeidelM

AlderwickLJ

BirchHL

SahmH

EggelingL

2007 Identification of a novel arabinofuranosyltransferase AftB involved in a terminal step of cell wall arabinan biosynthesis in Corynebacterianeae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J Biol Chem 282 14729 14740

14. SeidelM

AlderwickLJ

SahmH

BesraGS

EggelingL

2007 Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis. Glycobiology 17 210 219

15. LiuJ

MushegianA

2003 Three monophyletic superfamilies account for the majority of the known glycosyltransferases. Protein Sci 12 1418 1431

16. LeeRE

MikusovaK

BrennanPJ

BesraGS

1995 Synthesis of the mycobacterial arabinose donor beta-D-arabinofuranosyl-1-monophosphoryldecaprenol, development of a basic arabinosyl-transferase assay, and identification of ethambutol as an arabinosyl transferase inhibitor. J Am Chem Soc 117 11829 11832

17. WoluckaBA

McNeilMR

de HoffmannE

ChojnackiT

BrennanPJ

1994 Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J Biol Chem 269 23328 23335

18. AminAG

GoudeR

ShiL

ZhangJ

ChatterjeeD

2008 EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis. Microbiology 154 240 248

19. GoudeR

AminAG

ChatterjeeD

ParishT

2008 The critical role of embC in Mycobacterium tuberculosis. J Bacteriol 190 4335 4341

20. RamaswamySV

AminAG

GokselS

StagerCE

DouSJ

2000 Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 44 326 336

21. BorastonAB

BolamDN

GilbertHJ

DaviesGJ

2004 Carbohydrate-binding modules: fine-tuning polysaccharide recognition. Biochem J 382 769 781

22. HardingMM

2001 Geometry of metal-ligand interactions in proteins. Acta Crystallogr D Biol Crystallogr 57 401 411

23. HolmL

SanderC

1996 Mapping the protein universe. Science 273 595 603

24. IguraM

MaitaN

KamishikiryoJ

YamadaM

ObitaT

2008 Structure-guided identification of a new catalytic motif of oligosaccharyltransferase. EMBO J 27 234 243

25. LeeRE

BrennanPJ

BesraGS

1997 Mycobacterial arabinan biosynthesis: the use of synthetic arabinoside acceptors in the development of an arabinosyl transfer assay. Glycobiology 7 1121 1128

26. PiresVM

HenshawJL

PratesJA

BolamDN

FerreiraLM

2004 The crystal structure of the family 6 carbohydrate binding module from Cellvibrio mixtus endoglucanase 5a in complex with oligosaccharides reveals two distinct binding sites with different ligand specificities. J Biol Chem 279 21560 21568

27. BardarovS

BardarovSJJr

PavelkaMSJJr

SambandamurthyV

LarsenM

2002 Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148 3007 3017

28. BhamidiS

SchermanMS

McNeilMR

2009 Mycobacterial cell wall arabinogalactan: a detailed perspective on structure, biosynthesis, functions and drug tageting.

UllrichM

Bacterial polysaccharides Norfolk, UK Caister Academic Press 39 65

29. WalserPJ

HaebelPW

KunzlerM

SargentD

KuesU

2004 Structure and functional analysis of the fungal galectin CGL2. Structure 12 689 702

30. Van DuyneGD

StandaertRF

KarplusPA

SchreiberSL

ClardyJ

1993 Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol 229 105 124

31. KabschW

1993 Automatic processing of rotation diffraction data from crystals of initially unknown cell constants and symmetry. J Appl Crystallogr 26 795 800

32. SheldrickGM

2008 A short history of SHELX. Acta Crystallogr A 64 112 122

33. de la FortelleE

BricogneG

1997 Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multi-wavelength anomalous diffraction methods. Methods Enzymol 276 472 494

34. AbrahamsJP

LeslieAG

1996 Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallogr D Biol Crystallogr 52 30 42

35. MorrisRJ

PerrakisA

LamzinVS

2002 ARP/wARP's model-building algorithms. I. The main chain. Acta Crystallogr D Biol Crystallogr 58 968 975

36. EmsleyP

CowtanK

2004 Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60 2126 2132

37. MurshudovGN

VaginAA

DodsonEJ

1997 Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53 240 255

38. AdamsPD

Grosse-KunstleveRW

HungLW

IoergerTR

McCoyAJ

2002 PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58 1948 1954

39. WinnMD

IsupovMN

MurshudovGN

2001 Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 57 122 133

40. SchuckP

2000 Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J 78 1606 1619

41. StoverCK

de la CruzVF

FuerstTR

BurleinJE

BensonLA

1991 New use of BCG for recombinant vaccines. Nature 351 456 460

42. NigouJ

GilleronM

CahuzacB

BouneryJD

HeroldM

1997 The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guerin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J Biol Chem 272 23094 23103

43. GouetP

CourcelleE

StuartDI

MetozF

1999 ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15 305 308

44. Jamal-TalabaniS

BorastonAB

TurkenburgJP

TarbouriechN

DucrosVM

2004 Ab initio structure determination and functional characterization of CBM36; a new family of calcium-dependent carbohydrate binding modules. Structure 12 1177 1187

45. van BuerenAL

MorlandC

GilbertHJ

BorastonAB

2005 Family 6 carbohydrate binding modules recognize the non-reducing end of beta-1,3-linked glucans by presenting a unique ligand binding surface. J Biol Chem 280 530 537

46. HenshawJ

Horne-BitschyA

van BuerenAL

MoneyVA

BolamDN

2006 Family 6 carbohydrate binding modules in beta-agarases display exquisite selectivity for the non-reducing termini of agarose chains. J Biol Chem 281 17099 17107

47. DavisIW

Leaver-FayA

ChenVB

BlockJN

KapralGJ

2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35 W375 83

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#